about
Osmotic therapies added to antibiotics for acute bacterial meningitisMethodological challenges in measuring vaccine effectiveness using population cohorts in low resource settingsStavudine toxicity in adult longer-term ART patients in Blantyre, MalawiA prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, MalawiHousehold air pollution and the lung microbiome of healthy adults in Malawi: a cross-sectional studyDetection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control studyChallenges in reducing group B Streptococcus disease in African settings.Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study.Genetic characterisation of Malawian pneumococci prior to the roll-out of the PCV13 vaccine using a high-throughput whole genome sequencing approachIntracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa.When enough is enough: how the decision was made to stop the FEAST trial: data and safety monitoring in an African trial of Fluid Expansion As Supportive Therapy (FEAST) for critically ill childrenSurveillance Programme of IN-patients and Epidemiology (SPINE): implementation of an electronic data collection tool within a large hospital in Malawi.Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.Platelet and soluble CD40L in meningococcal sepsis.Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function.Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.Validity of US norms for the Bayley Scales of Infant Development-III in Malawian children.Longitudinal lactate levels from routine point-of-care monitoring in adult Malawian antiretroviral therapy patients: associations with stavudine toxicitiesBacterial meningitis in Malawian infants <2 months of age: etiology and susceptibility to World Health Organization first-line antibiotics.Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.Sequential acquisition of T cells and antibodies to nontyphoidal Salmonella in Malawian childrenIncomplete recovery of pneumococcal CD4 T cell immunity after initiation of antiretroviral therapy in HIV-infected malawian adults.Diagnosis of childhood tuberculosis and host RNA expression in Africa.Loss of Humoral and Cellular Immunity to Invasive Nontyphoidal Salmonella during Current or Convalescent Plasmodium falciparum Infection in Malawian ChildrenImpaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adultsInvasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.Prevalence and spectrum of illness among hospitalized adults with malaria in Blantyre, Malawi.Human melioidosis, Malawi, 2011.Genotypic homogeneity of multidrug resistant S. Typhimurium infecting distinct adult and childhood susceptibility groups in Blantyre, Malawi.A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi.Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi.CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations.Regulation of naturally acquired mucosal immunity to Streptococcus pneumoniae in healthy Malawian adults and children.Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young childrenRecognising and treatment seeking for acute bacterial meningitis in adults and children in resource-poor settings: a qualitative study.High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from MalawiCryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.Sepsis carries a high mortality among hospitalised adults in Malawi in the era of antiretroviral therapy scale-up: a longitudinal cohort study.Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac
P50
Q24198273-18F6AC6F-D9E1-4919-94BD-2CD2550D5EF1Q26800157-BB0354AA-055E-404A-834F-01EB2E09F2BAQ28481581-04AB3271-1F59-4977-99AC-1E8B0A6E4526Q28534417-ABAAB8A6-E15E-4590-AB2F-A6FEC125F3E8Q28597911-B7FC8479-5066-46EE-AE77-F56F9E9FA677Q28662246-AA114F1C-04C0-4531-A00F-B3028F25C5DBQ30241490-AB46DA6B-6D7A-4971-AABF-20403594F09EQ30382186-BBFCDCE0-30FC-4BBF-9911-6AE58B4EE213Q30421183-69DC25F4-9CE9-4DCE-99C3-C5A1ECD6F3DEQ30421768-28641110-640E-4325-8642-D281987297CDQ30607444-53C1FD27-A8CC-43AD-A56B-44002622A5A1Q30612047-84205B31-19EC-4DEF-A895-ED8F74B2843DQ31072142-09457A7F-24FD-42C8-8B64-EEDE46068B42Q33184132-8FF7986F-043B-4065-96BE-27C8D704EB7FQ33371797-CD71AE87-FF4B-4726-836F-98A71D6229DBQ33562292-87CB969E-FED0-4BB1-B91F-E5D6BEC556FDQ33589777-87417C96-2E36-40C6-B093-3E04C9A4F280Q33603689-5146E1E0-DAAE-4A01-B6FD-C07E8D810B9EQ33621094-4CE6B6B5-FC4E-46C5-92A5-B5DA10DFFAD0Q33630042-B2A9297F-9256-4ED1-9145-88A753057ABEQ33706348-76ECD461-4A0F-4530-95C0-378D13B939ADQ33745704-A2DB7AFC-1A39-4772-A7D5-C43AC8079EC1Q33800556-F44C2051-F938-4F43-BEB6-0602D741DC58Q33803127-04DFB5E7-2A9B-41EE-9A6A-B5528CA79EF8Q33876188-BF088A6A-2DAA-42AD-ABE0-F4858CABA52EQ34043394-CE95F874-5D99-4D05-BC7D-2108F7064AC9Q34275116-5B0955D1-0C05-467F-A117-C39763FF1ABFQ34309422-1D5FF983-6DD1-46ED-962D-4510D5AB26F6Q34348592-53B3DE85-7C21-4306-ADAF-3A9B5617C14BQ34359491-19DEBD50-22EE-4369-BAD5-0439DE73BCFDQ34465185-D522C1EF-D3A2-4855-96C4-BF838A0F54C6Q34489764-9AA5A3D7-B0C0-4128-9C99-FC559165241FQ34495636-BF28E782-B246-4119-A1CF-718B0C8AB52BQ34531875-0DAF7D06-57DB-4279-99EF-8B2738463588Q34539781-31EA3755-C9BE-4A33-82BB-09E6EBD7E0BCQ34826982-778CF7C9-E59A-400D-901D-F3E0F96697B5Q34874445-6EAB132D-F3B9-490B-A58B-4C24DD917388Q34895613-2D9810DA-08E3-4801-9934-159188585169Q34919361-AF95BE40-B9B4-48C1-A3D9-96678FFC23D7Q34975624-83DAB126-FDF1-4226-B10A-A7CD8F5FF794
P50
description
researcher ORCID ID = 0000-0003-4573-449X
@en
wetenschapper
@nl
name
Robert Heyderman
@ast
Robert Heyderman
@en
Robert Heyderman
@es
Robert Heyderman
@nl
type
label
Robert Heyderman
@ast
Robert Heyderman
@en
Robert Heyderman
@es
Robert Heyderman
@nl
prefLabel
Robert Heyderman
@ast
Robert Heyderman
@en
Robert Heyderman
@es
Robert Heyderman
@nl
P106
P21
P31
P496
0000-0003-4573-449X